27 Jul 2025 (51 Days) Date | | - Cons. EPS | - EPS |
26 Feb 2025 Date | | - Cons. EPS | - EPS |
25 Oct 2024 Date | | - Cons. EPS | - EPS |
23 Oct 2024 Date | | - Cons. EPS | - EPS |
28 Aug 2024 Date | | - Cons. EPS | - EPS |
27 Jul 2025 (51 Days) Date | | - Cons. EPS | - EPS |
26 Feb 2025 Date | | - Cons. EPS | - EPS |
25 Oct 2024 Date | | - Cons. EPS | - EPS |
23 Oct 2024 Date | | - Cons. EPS | - EPS |
28 Aug 2024 Date | | - Cons. EPS | - EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Ms. Nan-Maree Schoerie Dip Chem CEO | ASX Exchange | AU0000052490 ISIN |
Australia Country | - Employees | - Last Dividend | 25 Nov 2024 Last Split | - IPO Date |
ECS Botanics Holdings Ltd is a pioneering company stationed in Murrabit, Australia, firmly planted in the agricultural sector with a specialized focus on the cultivation, manufacture, and distribution of medicinal cannabis products. Catering primarily to the rising demand in Northwest Victoria, the organization leverages the fertile grounds and conducive climate of the region to produce high-grade cannabis. With its roots deeply embedded in agricultural expertise, ECS Botanics Holdings Ltd aims to redefine the medicinal cannabis landscape by merging traditional farming practices with innovative cultivation techniques, ensuring the availability of premium cannabis products for medicinal purposes.